Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats

Hypertension Research

Volumn 28, Issue 5, 2005, Pages 457-464

  Kirimura, Kazuyoshi ^a,b   Takai, Shinji ^a   Jin, Denan ^a   Muramatsu, Michiko ^a   Kishi, Kanta ^a   Yoshikawa, Katsuhiro ^a   Nakabayashi, Mika ^a   Mino, Yoshiki ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Environmental Biological Life Science Research Center Inc   (Japan)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Chymase; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN I; CANDESARTAN HEXETIL; CHYMASE; CHYMASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA; N [1 BENZYL 2,3 DIOXO 6 (2 PYRIDYLOXY)HEXYL] 2 (5 FORMYLAMINO 1,6 DIHYDRO 6 OXO 2 PHENYL 1 PYRIMIDINYL)ACETAMIDE; TRANDOLAPRILAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; ESSENTIAL HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PROTEIN EXPRESSION; RAT; RAT STRAIN; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BLOOD PRESSURE; BODY WEIGHT; CHYMASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER; SERINE ENDOPEPTIDASES; VASOCONSTRICTION;

EID: 22444444389     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.28.457     Document Type: Article

References (33)

1. Le Trong H, Parmelee DC, Walsh KA, Neurath H, Woodbury RG: Amino acid sequence of rat mast cell protease I (chymase). [i#Biochemistry#1i] 1987; [b#26#1b]: 6988-6994.
2. Benfey PN, Yin FH, Leder P: Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and a multi-gene family. [i#J Biol Chem#1i] 1987; [b#262#1b]: 5377-5384.
3. Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwartz LB: Angiotensin I conversion by human and rat chymotryptic protemases. [i#J Invest Dermatol#1i] 1984; [b#83#1b]: 336-339.
4. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. [i#J Biol Chem#1i] 1990; [b#265#1b]: 22348-22357.
5. Takai S, Shiota N, Sakaguchi M, Muraguchi H, Matsumura E, Miyazaki M: Characterization of chymase from human vascular tissues. [i#Clin Chim Acta#1i] 1997; [b#265#1b]: 13-20.
6. Chandrasekharan UM, Sanker S, Glynias MJ, Karnik SS, Husain A: Angiotensin II-forming activity in a reconstructed ancestral chymase. [i#Science#1i] 1996; [b#271#1b]: 502-505.
7. Jin D, Takai S, Yamada M, Sakaguchi M, Miyazaki M: The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats. [i#Jpn J Pharmacol#1i] 2000; [b#84#1b]: 449-454.
8. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, Arakawa K: Differences in tissue angiotensin II-forming pathways by species and organs [i#in vitro. Hypertension#1i] 1998; [b#32#1b]: 514-520.
9. Guo C, Ju H, Leung D, Massaeli H, Shi M, Rabinovitch M: A novel vascular smooth muscle chymase is upregulated in hypertensive rats. [i#J Clin Invest#1i] 2001; [b#107#1b]: 703-715.
10. Ju H, Gros R, You X, Tsang S, Husain M, Rabinovitch M: Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. [i#Proc Natl Acad Sci USA#1i] 2001; [b#98#1b]: 7469-7474.
11. Tsunemi K, Takai S, Nishimoto M, [i#et al#1i]: Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta. [i#Hypertens Res#1i] 2002; [b#25#1b]: 817-822.
12. Takai S, Jin D, Sakaguchi M, Miyazaki M: Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. [i#Hypertens Res#1i] 2004; [b#27#1b]: 213-219.
13. Yao YL, Ishihara T, Takai S, Miyazaki M, Mita S: Association between the expression of mast cell chymase and intraperitoneal adhesion formation in mice. [i#J Surg Res#1i] 2000; [b#92#1b]: 40-44.
14. Takai S, Shiota N, Jin D, Miyazaki M: Functional role of chymase in angiotensin II formation in human vascular tissue. [i#J Cardiovasc Pharmacol#1i] 1998; [b#32#1b]: 826-833.
15. Takai S, Jin D, Sakaguchi M, Miyazaki M: Chymase-dependent angiotensin II formation in human vascular tissue. [i#Circulation#1i] 1999; [b#100#1b]: 654-658.
16. Rouleau A, Garbarg M, Schwartz JC, Ruat M: Molecular cloning of rat mast cell protease 1 and development of specific probes for its gene transcript. [i#Biochem Biophys Res Commun#1i] 1994; [b#199#1b]: 593-602.
17. Ide H, Itoh H, Tomita M, [i#et al#1i]: Cloning of the cDNA encoding a novel rat mast-cell proteinase, rMCP-3, and its expression in comparison with other rat mast-cell proteinases. [i#Biochem J#1i] 1995; [b#311#1b]: 675-680.
18. Muramatsu M, Katada J, Hayashi I, Majima M: Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. [i#J Biol Chem#1i] 2000; [b#275#1b]: 5545-5552.
19. Okunishi H, Kawamoto T, Kurobe Y, [i#et al#1i]: Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. [i#Clin Exp Pharmacol Physiol#1i] 1991; [b#18#1b]: 649-659.
20. Morishita R, Higaki J, Okunishi H, [i#et al#1i]: Effect of long-term treatment with an angiotensin-converting enzyme inhibitor on the renin-angiotensin system in spontaneously hypertensive rats. [i#Clin Exp Pharmacol Physiol#1i] 1991; [b#18#1b]: 685-690.
21. Shiota N, Rysa J, Kovanen PT, Ruskoaho H, Kokkonen JO, Lindstedt KA: A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. [i#J Hypertens#1i] 2003; [b#21#1b]: 1935-1944.
22. Vartio T, Seppa H, Vaheri A: Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. [i#J Biol Chem#1i] 1981; [b#256#1b]: 471-477.
23. Leskinen MJ, Lindstedt KA, Wang Y, Kovanen PT: Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions. [i#Arterioscler Thromb Vasc Biol#1i] 2003; [b#23#1b]: 238-243.
24. Lindstedt KA, Wang Y, Shiota N, [i#et al#1i]: Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. [i#FASEB J#1i] 2001; [b#15#1b]: 1377-1388.
25. Wang Y, Shiota N, Leskinen MJ, Lindstedt KA, Kovanen PT: Mast cell chymase inhibits smooth muscle cell growth and collagen expression [i#in vitro#1i]: transforming growth factor-beta1-dependent and -independent effects. [i#Arterioscler Thromb Vasc Biol#1i] 2001; [b#21#1b]: 1928-1933.
26. Kraneveld AD, Muis T, Koster AS, Nijkamp FP: Role of mucosal mast cells in early vascular permeability changes of intestinal DTH reaction in the rat. [i#Am J Physiol#1i] 1998; [b#274#1b]: G832-G839.
27. Takai S, Jin D, Nishimoto M, [i#et al#1i]: Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein. [i#Life Sci#1i] 2001; [b#69#1b]: 1725-1732.
28. Takai S, Miyazaki M: Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation. [i#Cardiovasc Drug Rev#1i] 2003; [b#21#1b]: 185-198.
29. Yao L, Takai S, Nagai Y, [i#et al#1i]: Contribution of chymase to the activation of the transforming growth factor-beta/smad2 pathway and renal injury in Dahl-salt sensitive hypertensive rats. [i#Hypertension#1i] 2004; [b#44#1b]: 551 (Abstract).
30. Koga T, Urata H, Inoue Y, [i#et al#1i]: Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy. [i#Hypertens Res#1i] 2003; [b#26#1b]: 759-768.
31. Li M, Liu K, Michalicek J, [i#et al#1i]: Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. [i#J Clin Invest#1i] 2004; [b#114#1b]: 112-120.
32. Fukuda M, Ohkubo T, Katsuya T, [i#et al#1i]: Association of a mast cell chymase gene variant with HDL cholesterol, but not with blood pressure in the Ohasama study. [i#Hypertens Res#1i] 2002; [b#25#1b]: 179-184.
33. Ono K, Kokubo Y, Mannami T, Inamoto N, Shioji K, Iwai N: Heterozygous disruption of CMA1 does not affect blood pressure. [i#J Hypertens#1i] 2004; [b#22#1b]: 103-109.